2023 Clinic Nuclear Medicine PET Scan 
AuntMinnie
MARCH 26, 2024
Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.
AuntMinnie
OCTOBER 27, 2023
Patients with less tau pathology on PET scans may respond better to treatment with the new Alzheimer’s disease drug donanemab, according to an October 25 news report in the journal Practical Neurology. Food and Drug Administration, with a decision expected by the end of 2023. The full report is available here.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Imaging Technology
JUNE 24, 2023
mtaschetta-millane Sat, 06/24/2023 - 15:00 June 24, 2023 — A newly developed technology called “augmented whole-body scanning via magnifying PET” ( AWSM-PET ) has been shown to enhance the image resolution and system sensitivity of clinical whole-body PET/CT imaging. Louis, Missouri.
AuntMinnie
OCTOBER 2, 2024
tesla MRI AI body composition analysis Cardiac PET Cryo/thermoablation CT colonography Genicular artery embolization Hyperpolarized xenon-129 MRI PET/MRI Photon-counting CT Radiomics Theranostics Whole-body MRI screening Image of the Year 3D PET/MR image. PET scans predict patient response to Pluvicto.
Imaging Technology
JUNE 24, 2023
mtaschetta-millane Sat, 06/24/2023 - 17:00 June 24, 2023 — A new ultra-high resolution (UHR) brain PET scanner may have the ability to characterize previously indistinguishable brain regions that are known to be involved in Alzheimer’s disease , depressive disorders, visual attention disorders, tinnitus, and other conditions.
AuntMinnie
JUNE 20, 2024
Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.
Imaging Technology
MAY 31, 2023
milla1cf Wed, 05/31/2023 - 20:52 May 31, 2023 — GE HealthCare announced US FDA 510(k) clearance of Precision DL – a new, revolutionary deep learning-based image processing software included in GE HealthCare’s growing Effortless Recon DL portfolio. Gallen in Switzerland [vii]. iv] Omni Legend 32 cm has up to 2.2
Expert insights. Personalized for you.
122 
Let's personalize your content